D'Silva Andrew J. 4
4 · OptimizeRx Corp · Filed Oct 7, 2025
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
D'Silva Andrew J.
Chief Business Officer
Transactions
- Award
Common Stock
2025-08-21+10,417→ 47,514 total - Award
Stock Option
2025-08-21+23,437→ 23,437 totalExercise: $16.14Exp: 2030-08-21→ Common Stock (23,437 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.
- [F2]The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.